Merck biosimilar made available on the US VA National Formulary
The US Department of Veteran Affairs awarded a national contract for Merck’s biosimilar to be available on its National Formulary.
Archives for October 12, 2018
Be the Match partners to improve traceability of cell and gene therapies
Be the Match BioTherapies and Cryoport have collaborated to enhance supply chain services in the cell and therapy industry.
CPhI Worldwide 2018
Samsung BioLogics opens third plant, contemplates a fourth in Korea
The CDMO’s third biomanufacturing plant, regarded the world’s largest, is now operational in South Korea.
Mammalian plant a convenient option for growing Asian client base, says AGC
AGC Biologics has announced plans to build a mammalian cell culture facility in Japan, where the company says demand is growing for antibody-based therapies.